Based on doctors’ recommendations, women aged 35 and higher are likely to have amniocentesis, which will reveal whether a fetus has trisomy-21. Conversely, amniocentesis is not recommended for women under 35. As a consequence, women aged 35 and higher are more likely to learn that a baby will be born with Down syndrome and choose to terminate the pregnancy. This prenatal testing therefore reduces the incidence of babies born with Down syndrome among women 35 and over, but not among women under 35. Among women under 35, the rate of babies born with Down syndrome is much more likely to be almost the same as the incidence of fetuses having trisomy-21.